Oncology & Cancer

Breast cancer recurrence defined by hormone receptor status

Human epidermal growth factor (HER2) positive breast cancers are often treated with the same therapy regardless of hormone receptor status. New research published in BioMed Central's open access journal Breast Cancer Research ...

Oncology & Cancer

Not all tumor cells are equal

A new study led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of Bellvitge Biomedical Research Institute (IDIBELL), ICREA researcher and Professor of Genetics at University of Barcelona ...

Oncology & Cancer

Decoding chronic lymphocytic leukemia

A paper published online on June 13 in the Journal of Experimental Medicine identifies new gene mutations in patients with chronic lymphocytic leukemia (CLL) -- a disease often associated with lack of response to chemotherapy ...

Oncology & Cancer

Metabolic profiles essential for personalizing cancer therapy

One way to tackle a tumor is to take aim at the metabolic reactions that fuel their growth. But a report in the February Cell Metabolism shows that one metabolism-targeted cancer therapy will not fit all. That means that ...

Autism spectrum disorders

Six developmental trajectories ID'd in children with autism

(HealthDay) -- Six longitudinal developmental trajectories have been identified among children with autism, with significant heterogeneity seen in developmental pathways within these trajectories, according to a study published ...

Arthritis & Rheumatism

Updated systemic lupus erythematosus management recommendations

Systemic lupus erythematosus (SLE) is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...

page 2 from 8